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ABSTRACT
Ethanolic extracts prepared from the leaves of Psidium guajava were evaluated for anti-trypanosoma 
and cytotoxicity activity in the bloodstream species of Trypanosoma brucei brucei (BS427) and HEK293 in 
384-well Alamar Blue assays respectively. Cytotoxicity activity in HEK293 cells was subsequently used to 
estimate the selectivity index of the extracts. The activities of the plant extracts were determined to evaluate if 
further chemical and biological profi ling may be warranted for potential development in early drug discovery 
for African Sleeping Sickness. Two trypanocides, pentamidine and diminazene, were employed as reference 
drugs, while puromycin was also included as control for general cell growth inhibition. The results show that 
the extracts inhibited growth of T. b. brucei with an IC50 of 6.3 μg/mL and 48.9 μg/mL for 80% and 20% 
ethanolic preparations respectively, with corresponding activity of less than 50% against HEK293 at the highest 
screening dose of 238.10 μg/mL. The estimated selectivity index of the extracts compares favourably with 
pentamidine and diminazene. Meanwhile the reference compounds were found to have activities in agreement 
with published sensitivities at the doses screened. The lack of cytotoxicity at the doses screened and direct 
activity against T. b. brucei whole cells, make these extracts suitable candidates for further chemical elucidation 
and biological profi ling.
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Introduction
Human African Trypanosomosis (HAT) is a disease caused by two trypanosome 
species and there is an approximate incidence of around 50,000 cases annually 
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(ADEYEMI et al., 2011). Current drugs used for chemotherapy against HAT have problems 
with toxicity, duration and cost of treatment, and the need for intravenous injection. 
Melarsoprol, one of the few drugs effective against the second stage of the disease, is 
reported to cause encephalopathy in 10 - 15% of patients, of which 40% of cases are fatal 
(BLUM et al., 2001). These factors highlight the need to discover new active and less toxic 
compounds against HAT for future drug development. Natural products are a potential 
source of compounds for drug discovery as they contain a large number of molecules 
which may be bioactive. There are a number of anti-protozoal drugs which have natural 
product sources, including quinine and artemisinin for the treatment of malaria (HOET et 
al., 2004a). Traditional medicines have also used natural products, mainly of plant origin, 
for the treatment of a variety of diseases, including intestinal amoebiasis (TONA et al., 
1999), malaria (ASASE and OPPONG-MENSAH, 2009), helmenitic diseases and bacterial 
infections (OLIVER-BEVER, 1983). There have been a number of reports on the activity 
of various plant extracts used in herbal medicines against the causative species of HAT, 
or T. b. brucei, a related non-infective species, commonly used in early drug discovery 
for HAT (YABU et al., 1998; HOET et al., 2004a; ADERBAUER et al., 2008; SHUAIBU et al., 
2008). Psidium guajava or guava, has been used for a number of traditional medicine 
applications (GUTIERREZ et al., 2008; ELEKWA et al., 2009), including the decoction of 
the leaves or bark of P. guajava as a cure for diarrheal diseases (TONA et al., 1999), and 
relief of coughs, sore throats and infl amed gums (NWINYI et al., 2008). Preparations of the 
plant have also been used in traditional medicines for the treatment of malaria (ASASE and 
OPPONG-MENSAH, 2009) and trypanosomosis in animals (ATAWODI et al., 2002). In vitro 
activity of stem bark on chloroquine resistant Plasmodium falciparum has been reported 
(NUNDKUMAR and OJEWOLE, 2002). Recent studies have shown that an ethanolic extract 
of P. guajava leaf decreased T. b. brucei parasitaemia in rats and increased survival time 
in relation to untreated controls (ADEYEMI et al., 2009). Here the activities of the P. 
guajava extracts in comparison with reference compounds were investigated to determine 
if further chemical and biological profi ling may be warranted for potential development 
in early drug discovery for African Sleeping Sickness. 
Materials and methods
Plant collection and extract preparation. Fresh samples of P. guajava leaves were 
collected from a local farm in Ilorin, Kwara State, Nigeria. Relevant approval was duly 
obtained from the local authority prior to harvesting the plant leaves for this study. The 
leaves were identifi ed and authenticated at the Herbarium Unit of the Department of 
Plant Biology, University of Ilorin, Nigeria and a voucher specimen was deposited in the 
department for reference purpose, Registry number 250808.
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Two plant extracts were prepared with (A) 20% v/v ethanol/distilled water and (B) 
80% v/v ethanol/distilled water. The leaf extract of the plant was prepared according to 
the method described by VIEIRA et al. (2001). Fresh samples of P. guajava leaves were 
air dried and ground. A portion of the ground sample, weighing 300 g, was soaked in 
20% (v/v) ethanol/distilled water and left for 24 hours. The mixture was fi ltered using 
Whatman No. 1 fi lter paper and the fi ltrate concentrated in vacuo. The concentrate was 
then evaporated to dryness at 40 oC to obtain a dry extract sample, which was subsequently 
used to prepare the extract (A). The percentage yield was 2.46% (7.38 g). For extract B, 
a portion of the ground sample weighing 300 g was soaked in 80% (v/v) ethanol/distilled 
water and left for 24 hours. The mixture was fi ltered using Whatman No. 1 fi lter paper 
and the fi ltrate concentrated in vacuo. The concentrate was then evaporated to dryness at 
40 oC to obtain a dry extract sample, which was subsequently used to prepare extract (B). 
The percentage yield was 3.98% (9.73g).
Extracts were vortexed in DMSO at high speed for approximately two minutes, mixed 
on a heated magnetic stirrer at 40 oC for 15 minutes, followed by sonication for fi fteen 
minutes at room temperature. The highest concentration solubilised using this approach 
was 60 mg/mL for both extracts A and B.
T. b. brucei Alamar Blue viability assay. T. b. brucei bloodstream strain 427 (BS427) 
were maintained in HMI-9 media (HIRUMI and HIRUMI, 1989) at a maximum concentration 
of 1-2 x106 cells/mL. Cells were maintained in 25 cm2 tissue culture fl asks at 37 oC and 
5% CO2 in a humidifi ed environment. The assay was performed as described previously 
by SYKES and AVERY (2009). Briefl y, cells were diluted in HMI-9 media and 55 μL per 
well were inoculated into black clear bottomed 384 well plates (Biosciences, Franklin 
Lanes, NJ USA) as previously described. Plates were then incubated for 24 hours at 
37 oC and 5% CO2. Two separate plates were prepared: one containing triplicate serial 
dilutions of extracts dissolved in 100% DMSO and controls in 100% DMSO. Screening 
controls consisted of one column of DMSO as the positive assay control, and one column 
of 2 mg/mL pentamidine in DMSO for 100% inhibition of growth. The second plate 
contained triplicate serial dilutions of the reference compounds pentamidine (Sigma, 
MO, USA), diminazene (Sigma, MO, USA) and puromycin (Calbiochem, LA, USA) 
in DMSO. Samples in each plate were diluted 1:21 in DMEM high glucose, 1% sodium 
pyruvate, 1% NEAA using a MinitrackTM robotic liquid handler (PerkinElmer, MA, 
USA) before addition of 5 μL of this volume to the assay plate. Plates were incubated 
for a further 48 hours before addition of a fi nal 10% concentration of Alamar Blue™ 
(Biosource, MD, USA). Incubation was continued for 2 hours at 37 oC and 5% CO2, then 
at room temperature for 22 hours. Wells were read at excitation 535 nm, emission 590 
nm on a Victor IITM Wallac plate reader (PerkinElmer, MA, USA). Extract and control 
experiments were repeated as three independent experiments and reference compounds 
repeated twice, with triplicates in each experiment.
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HEK293 cytotoxicity assay. HEK293 cells (ATCC) were maintained in 75 cm2 tissue 
culture fl asks in DMEM high glucose, 1% sodium pyruvate, 1% NEAA and 10% FBS. 
Cells were harvested from 70-80% confl uent fl asks and diluted to a density of 7.27 x 104 
cells/mL before inoculation of 55 μL into wells of black clear bottom 384 well plates 
(Biosciences, Franklin, NJ, USA). Extract and reference compound plates were prepared 
as described for the T. b. brucei assay, the exception was replacement of pentamidine as 
a negative growth control with no cell addition in one column of the plate. These plates 
were diluted to 1:21 in DMEM high glucose, 1% sodium pyruvate, 1% NEAA without 
FBS, using a MinitrackTM robotic liquid handler before addition of 5 μL of the diluted 
extract and reference compound samples to the cells. The additions of Alamar Blue and 
incubations were performed as described for the T. b. brucei assay, with the Alamar Blue 
dilution made in DMEM high glucose,1% sodium pyruvate,1% NEAA and 10% FBS. 
Extract and control experiments were repeated three times and reference compounds 
twice, with triplicates in each experiment.
Reference compound and extract activity analysis. The IC50 values of reference 
compounds and extracts were calculated by plotting % inhibition (100% inhibition was 
equal to 2 μM fi nal pentamidine in the T. b. brucei assay and no cells (media only) in the 
HEK293 assay, against log [reference compound/ extract] in GraphPad Prism 5. The IC50 
value was the concentration of compound estimated to result in 50% reduction in growth. 
One hundred % growth was calculated as an average of the DMSO control wells. IC50 
results were expressed as a mean ± SD. 
Results 
Extract activity in T. b. brucei and HEK293 viability assays. The IC50 values obtained 
for extracts are shown in Table 1 and Figs. 1 - 4. Extract A had an IC50 value of 48.94 
± 1.52 μg/mL, based on data obtained from three biological replicates, using dilutions 
made from a 238.10 μg/mL fi nal assay concentration of extract. The estimated IC50 value 
obtained for extract B was 6.33 ± 0.58 μg/mL. Cytotoxicity testing in the Alamar Blue 
HEK293 cell viability assay showed that extract A was 24.16 ± 5.10% active and extract 
B was 30.05 ± 4.89% active at 238.10 μg/mL. Both of the extracts displayed less than 
50% activity at a fi nal assay concentration of 238.10 μg/mL, with extract A exhibiting at 
least a 23 fold selectivity index and B at least a 5 fold selectivity index. 
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Table 1. Activity of P. guajava extracts and a panel of reference compounds in the T. b. brucei and 
HEK293 Alamar Blue assays
IC50 T. b. brucei
IC50 HEK293, or % 
activity at dose Selectivity index
Extract A (20%) 48.94 ± 1.52a 24.16 ± 5.10%c >23x
Extract B (80%) 6.33 ± 0.58a 30.05 ± 4.89%c >5x
Pentamidine 3.64 ± 0.21b 4.65 ± 9.52%d >91x
Diminazene 41.12 ± 3.63b 0.40 ± 10.94%e >936x
Puromycin 65.15 ± 14.78b 619.3 ± 47.65 9.5x
a = μg/mL, b = nM, c = at 238.10 μg/mL, d = 0.33 μM, e = 38.5 μM
Fig. 1. Activity of P. guajava leaf (20%) ethanolic extract in the T. b. brucei Alamar Blue assay
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Fig. 3. Activity of P. guajava leaf (20%) ethanolic extract in the HEK293 Alamar Blue assay
Fig. 4. Activity of P. guajava leaf (80%) ethanolic extracts in the HEK293 Alamar Blue assay
Reference compound activities in T. b. brucei and HEK293 viability assays. The 
activities of the reference drugs are shown in Table 1 and Figs. 5 - 6. The reference 
compounds did not exhibit activity greater than 50% in the HEK293 assay at the highest 
doses screened (0.33 μM and 38.5 μM for pentamidine and diminazene respectively). 
Therefore the selectivity index was at least 91 fold for pentamidine and at least 936 fold 
for diminazene. However for puromycin, activity in the HEK293 assay was greater than 
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Fig. 5. Reference compound activity in the T. b. brucei Alamar Blue assays
Fig. 6. Reference compound activity in the HEK293 Alamar Blue assay
Discussion
It has been reported that P. guajava leaf extracts demonstrated no cytotoxicity in 
clinical trials with humans (GUTIERREZ et al., 2008). Moreover a previous study detailing 
the cytotoxic and immune-modulatory NF-kappa B activities of P. guajava extract 
against MDA-MB231 and MCF7 cells was demonstrated (KAILEH et al., 2007). In a 
separate study, LING et al. (2010) reported that some ethanolic extracts including that of 
P. guajava lack cytotoxicity in assays involving 3T3 and 4T1 cells. However, to our 
knowledge, this is the fi rst report of direct in vitro anti-T. b. brucei activity of P. guajava 
extracts and supports previous observations of in vivo activity of a leaf extract to reduce 
parasitaemia in T. b. brucei infected rats (ADEYEMI et al., 2009). As a measure of the T. 
b. brucei assay performance, a series of reference compounds were screened alongside 
the assay to determine whether the trypanosome culture was being inhibited by known 
compounds, as previously characterised in this and other assay systems (SYKES and 
AVERY, 2009). Extract A had an IC50 value of 48.94 ± 1.52 μg/mL, based on data obtained 
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concentration of extract. The estimated IC50 value obtained for extract B was 6.33 ± 0.58 
μg/mL. Both of the extracts displayed less than 50% activity at a fi nal assay concentration 
of 238.10 μg/mL, with extract A exhibiting at least a 23 fold selectivity index and B 
at least a 5 fold selectivity index which compare favourably with the reference drugs, 
except for puromycin, which had cytotoxicity activity greater than 50%. Pentamidine and 
diminazene did not exhibit activity greater than 50% in the HEK293 assay at the highest 
doses screened (0.33 μM and 38.5 μM for pentamidine and diminazene respectively). The 
selectivity index was at least 91 fold for pentamidine and at least 936 fold for diminazene. 
Puromycin is a general cell growth inhibitor of both eukaryotic and prokaryotic cells, 
with a mode of action via disruption of protein synthesis. Puromycin was found to be 
active on both cell lines, with less than 10 times the selectivity index estimated, which 
would be expected for such a compound with a non-specifi c mode of action. Pentamidine 
is a trypanocide used to treat HAT and diminazene is a veterinary drug used to treat T. 
b. brucei disease in animals. Both of these known drugs had IC50 values in agreement 
with relatively low nM sensitivities as previously observed in the Alamar Blue assay in 
384 well format, (29.8 nM and 91.8 nM, respectively; SYKES and AVERY, 2009) and also 
reported in 96 well formats (STEWART et al., 2005; LANTERI et al., 2006; MERSCHJOHANN 
and STEVERDING, 2006). Diminazene has been reported to have activities in various 
mammalian cancer cell lines, which have been commonly reported in the literature to 
determine cytotoxicity, including: a 3670 x selectivity index between HL-60 cells and T. 
b. brucei cells in an Alamar Blue assay (MERSCHJOHANN et al., 2001); an MIC of greater 
than 20 μM in an Alamar Blue assay estimating J774 macrophage cell viability (HOET 
et al., 2004); greater than 10-100 μM in a panel of carcinoma cell lines in an MTT assay 
(GONZALEZ et al., 1999) and 93.5 μM for L6 cells in an Alamar Blue assay (STEWART et 
al, 2005). Pentamidine has reported activities including an IC50 of 162 μM against empty 
vector transfected CHO cells (MING et al., 2009) and an IC50 value of 46.6 μM (BAKUNOV 
et al., 2008) and 2.53 μM (STEWART et al., 2005) against L6 cells in Alamar Blue based 
assays. These results are in agreement with the level of activity at the screened doses 
of these known drugs exhibited in the HEK293 assay. The assays reported here agree 
with previous reports of T. b. brucei and some mammalian cell line sensitivities at the 
screened doses for the series of compounds. This supports the validity of the estimated 
extract activity in these assays. This preliminary study suggests that the P. guajava leaf 
contains compounds with a synergistic effect that may have anti trypanosomal/ specifi c 
anti- HAT activity. Based upon the data presented here, further studies are warranted to 
include chemical isolation and biological profi ling of the compounds in these extracts for 
potential development in early HAT drug discovery. 
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Conclusion
The lack of cytotoxicity at the doses screened and direct activity against T. b. brucei 
whole cells make these extracts suitable candidates for further chemical elucidation 
and biological profi ling. Based upon the anti-T. b. brucei activity and selectivity of the 
extracts on T. b. brucei cells compared with HEK293, we recommend these extracts for 
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SAŽETAK
Istraženo je tripanocidno djelovanje etanolskog iscrpka lišća Psidium guajava na vrstu Trypanosoma 
brucei brucei (BS427) i njegova citotoksičnost na stanice HEK293 bojanjem alamarskim plavilom u 384 
jažice. Citotoksični učinak na stanice HEK293 rabljen je za procjenu indeksa selektivnosti. Učinkovitost biljnih 
iscrpaka određivana je da bi se procijenila svrhovitost budućih kemijskih i bioloških istraživanja potencijalnoga 
lijeka za afričku bolest spavanja. U istraživanju su rabljena dva tripanocida, pentamidin i diminazen, te 
puromicin kao sredstvo koje usporava rast stanica. Rezultati su pokazali da 80% etanolskih pripravaka s IC50 od 
6,3 μg/mL koči rast i razvoj tripanosoma, a samo 20% onih s IC50 od 48,9 μg/mL, s odgovarajućom aktivnosti 
manjom od 50% na stanice HEK293 u najvećoj dozi od 238,10 μg/mL. Indeks selektivnosti iscrpaka bio je 
sukladan s aktivnošću pentamidina i diminazena. Aktivnost istraživanih sastojaka bila je sukladna s razinom 
prije objavljene osjetljivosti. Izostanak citotoksičnosti na razini rabljenih koncentracija i izravna djelotvornost 
na stanice T. b. brucei daju osnovu za daljnja kemijska i biološka istraživanja predmetnih pripravaka.
Ključne riječi: alamarsko plavilo, Psidium guajava, Trypanosoma brucei brucei, vitalnost, HEK293, 
citotoksičnost
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